Pasteur Institute, Lille
Genes involved in murabutide-induced HIV suppression identified
Published in AIDS Weekly and Law, March 18th, 2004
"The synthetic immunomodulator murabutide has been found to suppress human immunodeficiency virus type-1 (HIV-1) replication, in macrophages, through a regulated expression of cellular factors needed at different steps in the virus replication cycle," virologists in France explained.
"To identify cellular genes implicated in the murabutide-induced virus inhibition," M.J. Truong and colleagues working at the Pasteur Institute in Lille "carried out a differential display analysis on HIV-1-infected macrophages that were treated, or not, with murabutide."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2004-03-18)
More Articles from AIDS Weekly and Law
- Adventrx Pharmaceuticals, Inc.
Cancer center receives grant for HIV/AIDS vaccine therapy - Medical Research Council Laboratories, Banjul
Cellular immunity similar for asymptomatic HIV-1 and -2-infected patients - United Nations
AIDS threat growing throughout Europe - World AIDS Foundation
Civil strife in Haiti could derail progress on HIV transmission rates - Abbott Diagnostika GmbH & Co. KG
New automated ELISA reduces detection time of HIV-specific antibodies - Bayer Pharmaceutical Corp.
Tat-binding surface of CBP KIX domain identified - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
